MorphoSys
Biotechnology company focused on the research and development of fully human antibodies.
Launch date
Employees
Market cap
$2.8b
Enterprise valuation
$2.7b (Public information from Jul 2024)
Share price
$18.96 MOR
Company register number HRB 121023 (München)
Planegg Bavaria (HQ)
Authorizing premium user...